JPRN-UMIN000046838
Recruiting
未知
atural history study of Duchenne muscular dystrophy focusing on upper limb motor function - Natural history study of Duchenne muscular dystrophy
ational Center of Neurology and Psychiatry0 sites100 target enrollmentFebruary 7, 2022
ConditionsDuchenne muscular dystrophy
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Duchenne muscular dystrophy
- Sponsor
- ational Center of Neurology and Psychiatry
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. The principal investigator or the research coordinator determined that he / she had behavioral abnormalities such as intellectual disability, autistic tendency, and attention deficit hyperactivity disorder that interfered with the implementation of motor function evaluation. 2\. Severe heart failure or respiratory failure makes it difficult to visit an outpatient clinic 3\. In addition, the principal investigator or the research coordinator judged that it was inappropriate as the subject of this research. 4\. Participating in clinical trials / clinical trials at baseline
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
utriceuticals in Duchenne muscular dystrophyDuchenne muscular dystrophyNeurological - Other neurological disordersHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersMusculoskeletal - Other muscular and skeletal disordersACTRN12610000462088The Royal Children's Hospital48
Recruiting
Not Applicable
Outcome measures in Duchenne Muscular Dystrophy: A Natural History StudyDuchenne Muscular Dystrophy1002839610028302NL-OMON50307eids Universitair Medisch Centrum20
Active, not recruiting
Not Applicable
Duchenne muscular dystrophy: a clinical trial to find the optimum steroid regimen.Duchenne muscular dystrophy boys between 4 and 8 years of age, able to rise from the floor without support, not previously treated with steroids.MedDRA version: 14.1Level: PTClassification code 10013801Term: Duchenne muscular dystrophySystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2010-023744-33-ITAZIENDA OSPEDALIERA DI PADOVA300
Active, not recruiting
Not Applicable
Trial to find best steroid treatment for Duchenne muscular dystrophyDuchenne muscular dystrophy (DMD)MedDRA version: 14.1Level: PTClassification code 10013801Term: Duchenne muscular dystrophySystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2010-023744-33-GBniversity of Rochester300
Active, not recruiting
Not Applicable
Bone Health in Duchenne Muscular Dystrophy- a case controlled study of Risedronate use - Risedronate in DMDBone Health in Duchenne Muscular Dystrophy- a randomised controlled study of Risedronate useEUCTR2009-017649-67-IEThe Central Remedial Clinic and The Children's University Hospital70